THE REALITY CHECK: 5 Assets Delivering Proof in a Speculative Market

Executive Summary

• Lake Victoria Gold reports expanded mineralization at Imwelo (Tanzania), a fully permitted mine with construction imminent; Barrick acquired non‑core Tembo licences with up‑to US$45 M contingent resource payments.
• Diginex Limited posted 293 % revenue growth for the six months ended 30 Sep 2025 and signed an MOU to acquire AI sustainability platform Plan A.
• Quantum Security Encryption Corp. (formerly Scope Technologies) launched the quantum‑resilient encryption kit qREK and completed its ticker change to CSE: QSE on Dec 8, 2025.
• GT Biopharma advanced its Phase 1 trial of GTB‑3650 to the next dose cohort, indicating safety committee clearance for a tri‑specific NK‑cell engager targeting aggressive leukemia.

Key Details

• Lake Victoria Gold (TSXV: LVG / OTCQB: LVGLF)
• Recent drilling shows mineralization extending well below the planned open‑pit shell; historical resource boundaries “shattered.”
• Imwelo Project is fully permitted; construction expected imminently.
• Barrick Gold purchased non‑core Tembo licences; transaction includes contingent payments up to US$45 M based on future resources.
• Diginex Limited (NASDAQ: DGNX)
• Revenue for the six months ended 30 Sep 2025 increased 293 % year‑over‑year.
• Signed a non‑binding MOU to acquire Plan A, an AI‑powered sustainability platform used by enterprises such as BMW; acquisition intended to centralize “Truth Architecture” for ESG data verification.
• Quantum Security Encryption Corp. (CSE: QSE)
• Rebranded from Scope Technologies; ticker change effective 8 Dec 2025.
• Launched qREK – Quantum‑Resilient Encryption Kit, enabling on‑device local key generation to eliminate transmission vulnerabilities.
• GT Biopharma, Inc. (NASDAQ: GTBP)
• Phase 1 trial of GTB‑3650 (Tri‑Specific NK Cell Engager) moved to the next dose cohort in November 2025, indicating safety committee approval for higher dosing.
• Trial targets patients with aggressive, treatment‑refractory leukemia; aims to demonstrate a favorable safety profile versus conventional chemotherapy.

Notable Quotes

• “The winners share one trait: They aren't selling dreams. They are building factories.” – Market commentary emphasizing tangible asset focus.
• “Our qREK kit eliminates the most vulnerable point of failure in the encryption chain by generating keys locally on the device.” – Quantum Security Encryption Corp. product statement.

Materiality Assessment: Material – Positive (the release contains multiple substantive operational, commercial, and financial updates that could materially affect investor perception and valuation.)